Invasive infection caused by Streptococcus dysgalactiae subsp. equisimilis: Characteristics of strains and clinical features

Journal of Infection and Chemotherapy

Volumn 17, Issue 1, 2011, Pages 1-10

  Takahashi, Takashi ^a   Ubukata, Kimiko ^a   Watanabe, Haruo ^b  

^a KITASATO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Clinical features; Emerging infectious disease; Invasive infection; Streptococcus agalactiae; Streptococcus dysgalactiae subsp. equisimilis; Streptococcus pyogenes

Indexed keywords

M PROTEIN; STREPTOCOCCUS VACCINE; STREPTOKINASE;

ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; CLINICAL FEATURE; HUMAN; INVASIVE BACTERIAL INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; REVIEW; SEQUENCE ANALYSIS; STREPTOCOCCUS DYSGALACTIAE EQUISIMILIS; STREPTOCOCCUS INFECTION;

EID: 79951557398     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-010-0084-2     Document Type: Review

References (70)

1. T Wajima SY Murayama K Sunaoshi E Nakayama K Sunakawa K Ubukata 2008 Distribution of emm type and antibiotic susceptibility of group A streptococci causing invasive and noninvasive disease J Med Microbiol 57 1383 1388 1:CAS:528:DC%2BD1cXhsVaqtrnE 10.1099/jmm.0.2008/002642-0 18927416
2. SY Murayama C Seki H Sakata K Sunaoshi E Nakayama S Iwata, et al. 2009 Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections Antimicrob Agents Chemother 53 2650 2653 1:CAS:528:DC%2BD1MXntFGksLY%3D 10.1128/AAC.01716-08 19332682
3. Takahashi T, Sunaoshi K, Sunakawa K, Fujishima S, Watanabe H, Ubukata K. Clinical aspects of invasive infections with Streptococcus dysgalactiae ssp. equisimilis in Japan: differences with respect to Streptococcus pyogenes and Streptococcus agalactiae infections. Clin Microbiol Infect. doi: 10.1111/j.1469-0691.2009.03047.x.
4. P Vandamme B Pot E Falsen K Kersters LA Devriese 1996 Taxonomic study of Lancefield streptococcal groups C, G, and L (Streptococcus dysgalactiae) and proposal of S. dysgalactiae subsp. equisimilis subsp. nov Int J Syst Bacteriol 46 774 781 1:STN:280:DyaK28zns1yhtQ%3D%3D 10.1099/00207713-46-3-774 8782689
5. LN Broyles C Van Beneden B Beall R Facklam PL Shewmaker P Malpiedi, et al. 2009 Population-based study of invasive disease due to β-hemolytic streptococci of groups other than A and B Clin Infect Dis 48 706 712 10.1086/597035 19187026
6. CH Liao LC Liu YT Huang LJ Teng PR Hsueh 2008 Bacteremia caused by group G streptococci, Taiwan Emerg Infect Dis 14 837 840 1:CAS:528: DC%2BD1cXntVOlsLk%3D 10.3201/eid1405.070130 18439377
7. R Cohen-Poradosu J Jaffe D Lavi S Grisariu-Greenzaid R Nir-Paz L Valinsky, et al. 2004 Group G streptococcal bacteremia in Jerusalem Emerg Infect Dis 10 1455 1460 15496248 (Pubitemid 39014160)
8. N Sylvetsky D Raveh Y Schlesinger B Rudensky AM Yinnon 2002 Bacteremia due to beta-hemolytic Streptococcus group G: increasing incidence and clinical characteristics of patients Am J Med 112 622 626 10.1016/S0002-9343(02)01117-8 12034411 (Pubitemid 34597162)
9. Brandt C, Spellerberg B. Streptococcus. In: Murray PR, Baron EJ, Landry ML, Jorgensen JH, Pfaller MA, editors. Manual of clinical microbiology. 9th ed. Washington: American Society for Microbiology; 2007. p. 412-29.
10. RC Lancefield 1933 A serological differentiation of human and other groups of hemolytic streptococci J Exp Med 57 571 595 1:STN:280: DC%2BC3crjs1Snsg%3D%3D 10.1084/jem.57.4.571 19870148
11. EI Garvie JAE Farrow MD Collins 1983 Streptococcus dysgalactiae (Diernhofer) nom. rev Int J Syst Bacteriol 33 404 405 10.1099/00207713-33-2-404 (Pubitemid 13136757)
12. Y Carmeli KL Ruoff 1995 Report of cases of and taxonomic considerations for large-colony-forming Lancefield group C streptococcal bacteremia J Clin Microbiol 33 2114 2117 1:STN:280:DyaK28%2FlslGqtA%3D%3D 7559958
13. LA Devriese 1991 Streptococcal ecovars associated with different animal species: epidemiological significance of serogroups and biotypes J Appl Bacteriol 71 478 483 1:STN:280:DyaK387jvVChsA%3D%3D 1778843
14. LA Devriese J Hommez R Kilpper-Bälz KH Schleifer 1986 Streptococcus canis sp. nov.: a species of group G streptococci from animals Int J Syst Bacteriol 36 422 425 10.1099/00207713-36-3-422 (Pubitemid 16057133)
15. JAE Farrow MD Collins 1984 Taxonomic studies on streptococci of serological groups C, G, and L and possibly related taxa Syst Appl Microbiol 5 483 493 (Pubitemid 15165532)
16. CM Brandt G Haase N Schnitzler R Zbinden R Lütticken 1999 Characterization of blood culture isolates of Streptococcus dysgalactiae subsp. equisimilis possessing Lancefield's group A antigen J Clin Microbiol 37 4194 4197 1:STN:280:DC%2BD3c%2FjtlKrtw%3D%3D 10565964
17. C Katsukawa A Tamaru Y Morikawa 2002 Streptococcus dysgalactiae subsp. equisimilis possessing Lancefield's group A antigen Kansenshogaku Zasshi 76 155 160 11974882
18. N Mitsuno T Hari N Tamagawa J Itoi E Ikeda K Hamasaki, et al. 2006 Evaluation of rapid diagnostic kits for the detection of group A streptococcus to Streptococcus pyogenes and Streptococcus spp. with Lancefield's group A antigen Kansenshogaku Zasshi 80 665 673 17176853
19. D Tanaka J Isobe M Watahiki Y Nagai C Katsukawa R Kawahara, et al. 2008 Genetic features of clinical isolates of Streptococcus dysgalactiae subsp. equisimilis possessing Lancefield's group A antigen J Clin Microbiol 46 1526 1529 1:CAS:528:DC%2BD1cXltFejsL8%3D 10.1128/JCM.02188-07 18305132 (Pubitemid 351563609)
20. KP Dierksen JR Tagg 2000 Haemolysin-deficient variants of Streptococcus pyogenes and S. dysgalactiae subsp. equisimilis may be overlooked as aetiological agents of pharyngitis J Med Microbiol 49 811 816 1:CAS:528:DC%2BD3cXmsFSltb8%3D 10966229 (Pubitemid 30666632)
21. PC Woo JL Teng SK Lau PN Lum KW Leung KL Wong, et al. 2003 Analysis of a viridans group strain reveals a case of bacteremia due to lancefield group G alpha-hemolytic Streptococcus dysgalactiae subsp. equisimilis in a patient with pyomyositis and reactive arthritis J Clin Microbiol 41 613 618 10.1128/JCM.41.2.613-618.2003 12574255 (Pubitemid 36184170)
22. T Horii S Izumida K Takeuchi T Tada J Ishikawa K Tsuboi 2006 Acute peritonitis and salpingitis associated with streptococcal toxic shock syndrome caused by Lancefield group G alpha-haemolytic Streptococcus dysgalactiae subsp. equisimilis J Med Microbiol 55 953 956 10.1099/jmm.0.46507-0 16772425 (Pubitemid 43974704)
23. T Takahashi R Asami K Tanabe Y Hirono Y Nozawa N Chiba, et al. 2010 Clinical aspects of invasive infection with Streptococcus dysgalactiae subsp. equisimilis in elderly patients J Infect Chemother 16 68 71 10.1007/s10156-009- 0016-1 20052513
24. A Kalia DE Bessen 2004 Natural selection and evolution of streptococcal virulence genes involved in tissue-specific adaptations J Bacteriol 186 110 121 1:CAS:528:DC%2BD2cXhsFCr 10.1128/JB.186.1.110-121.2004 14679231 (Pubitemid 38020293)
25. D Humar V Datta DJ Bast B Beall JC De Azavedo V Nizet 2002 Streptolysin S and necrotising infections produced by group G streptococcus Lancet 359 124 129 1:CAS:528:DC%2BD38XmsV2lsw%3D%3D 10.1016/S0140-6736(02)07371-3 11809255 (Pubitemid 34112541)
26. S Hashikawa Y Iinuma M Furushita T Ohkura T Nada K Torii, et al. 2004 Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome J Clin Microbiol 42 186 192 1:CAS:528:DC%2BD2cXht1Wntr0%3D 10.1128/JCM.42.1.186-192.2004 14715751 (Pubitemid 38082718)
27. A Geyer KH Schmidt 2000 Genetic organisation of the M protein region in human isolates of group C and G streptococci: two types of multigene regulator-like (mgrC) regions Mol Gen Genet 262 965 976 1:CAS:528: DC%2BD3cXhtlSisbc%3D 10.1007/PL00008665 10660058 (Pubitemid 30072126)
28. K Sunaoshi H Aburahashi R Kobayashi Y Yamamoto K Okuzumi A Yoshida, et al. 2006 Emm typing by genetic identification of Streptococcus dysgalactiae subsp. equisimilis and susceptibility to oral antibiotics Kansenshogaku Zasshi 80 488 495 17073261
29. K Sunaoshi SY Murayama K Adachi M Yagoshi K Okuzumi N Chiba, et al. 2010 Molecular emm genotyping and antibiotic susceptibility of Streptococcus dysgalactiae subsp. equisimilis isolated from invasive and non-invasive infections J Med Microbiol 59 82 88 1:CAS:528:DC%2BC3cXhsVyqu7s%3D 10.1099/jmm.0.013201-0 19745030
30. T Ikebe S Murayama K Saitoh S Yamai R Suzuki J Isobe, et al. 2004 Surveillance of severe invasive group-G streptococcal infections and molecular typing of the isolates in Japan Epidemiol Infect 132 145 149 1:CAS:528:DC%2BD2cXms1CltQ%3D%3D 10.1017/S0950268803001262 14979600 (Pubitemid 38240083)
31. Y Ahmad RE Gertz Jr Z Li V Sakota LN Broyles C Van Beneden, et al. 2009 Genetic relationships deduced from emm and multilocus sequence typing of invasive Streptococcus dysgalactiae subsp. equisimilis and S. canis recovered from isolates collected in the United States J Clin Microbiol 47 2046 2054 1:CAS:528:DC%2BD1MXpvFCjsr0%3D 10.1128/JCM.00246-09 19386831
32. Y Misawa S Okugawa K Ubukata K Okuzumi M Okada K Moriya, et al. 2006 A case of severe necrotizing cellulitis caused by group G Streptococcus dysgalactiae subsp. equisimilis Kansenshogaku Zasshi 80 436 439 16922490
33. K Ueno T Kawayama N Edakuni T Koga H Aizawa 2006 A case of thoracic empyema with gas formation associated with Streptococcus dysgalactiae subsp. equisimilis Kansenshogaku Zasshi 80 527 530 17073267
34. D Matsui Y Kitasato S Honda K Ueno A Tanaka N Edakuni, et al. 2007 A case of bacterial pneumonia caused by Streptococcus dysgalactiae subsp. equisimilis, showing patchy consolidations resembling organizing pneumonia Nihon Kokyuki Gakkai Zasshi 45 36 42 17313025
35. M Horibe Y Sano T Himeno M Ichikawa Y Ban H Kano, et al. 2008 Case of gas gangrene in both legs due to Streptococcus dysgalactiae subsp. equisimilis, resulting in amputation of right leg Nippon Naika Gakkai Zasshi 97 1879 1881 18788420
36. PV Bramhachari SY Kaul DJ McMillan MS Shaila MG Karmarkar KS Sriprakash 2010 Disease burden due to Streptococcus dysgalactiae subsp. equisimilis (group G and C streptococcus) is higher than that due to Streptococcus pyogenes among Mumbai school children J Med Microbiol 59 220 223 10.1099/jmm.0.015644-0 19833781
37. A Sing K Trebesius J Heesemann 2001 Diagnosis of Streptococcus dysgalactiae subspecies equisimilis (Group C streptococci) associated with deep soft tissue infections using fluorescent in situ hybridization Eur J Clin Microbiol Infect Dis 20 146 149 1:STN:280:DC%2BD3MzpsValtw%3D%3D 10.1007/s100960170001 11305474 (Pubitemid 32247117)
38. A Kumar J Sandoe N Kumar 2005 Three cases of vertebral osteomyelitis caused by Streptococcus dysgalactiae subsp. equisimilis J Med Microbiol 54 1103 1105 10.1099/jmm.0.46061-0 16192443 (Pubitemid 41566782)
39. MD Pinho J Melo-Cristino M Ramirez 2006 Clonal relationships between invasive and noninvasive Lancefield group C and G streptococci and emm-specific differences in invasiveness J Clin Microbiol 44 841 846 1:STN:280: DC%2BD287ivFOlsw%3D%3D 10.1128/JCM.44.3.841-846.2006 16517864
40. T Siljander M Karppelin S Vähäkuopus J Syrjänen M Toropainen J Kere, et al. 2008 Acute bacterial, nonnecrotizing cellulitis in Finland: microbiological findings Clin Infect Dis 46 855 861 10.1086/527388 18260753 (Pubitemid 351417186)
41. AI Fernández-Martínez MR Pascual D Cimas J Esteban 2008 Septic arthritis due to Streptococcus dysgalactiae ssp. equisimilis Enferm Infecc Microbiol Clin 26 670 671 10.1016/S0213-005X(08)75285-6 19100199
42. F Lestin S Mann A Podbielski 2008 Spondylodiscitis and paraspinal abscess caused by beta-haemolytic group G streptococci spreading from infected leg ulcers J Med Microbiol 57 1157 1160 10.1099/jmm.0.2008/000240-0 18719188
43. BR Kittang N Langeland S Skrede H Mylvaganam 2010 Two unusual cases of severe soft tissue infection caused by Streptococcus dysgalactiae subsp. equisimilis J Clin Microbiol 48 1484 1487 1:CAS:528:DC%2BC3cXmt1Kgu7k%3D 10.1128/JCM.01737-09 20147644
44. HA Lopardo P Vidal M Sparo P Jeric D Centron RR Facklam, et al. 2005 Six-month multicenter study on invasive infections due to Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis in Argentina J Clin Microbiol 43 802 807 10.1128/JCM.43.2.802-807.2005 15695683 (Pubitemid 40256037)
45. PC Woo AM Fung SK Lau SS Wong KY Yuen 2001 Group G beta-hemolytic streptococcal bacteremia characterized by 16S ribosomal RNA gene sequencing J Clin Microbiol 39 3147 3155 1:CAS:528:DC%2BD3MXnt1Wgurk%3D 10.1128/JCM.39.9. 3147-3155.2001 11526143 (Pubitemid 32830307)
46. T Takahashi M Yoshino M Morozumi N Chiba K Kishii SY Murayama K Ubukata 2010 Clinical aspects of invasive infection with Lancefield group B and G streptococci in elderly patients Kansenshogaku Zasshi 84 135
47. Yamaoka S, Ogihara T, Yasui M, Hasegawa M, Hira S, Oue S, et al. Neonatal streptococcal toxic shock syndrome caused by Streptococcus dysgalactiae subsp. equisimilis. Pediatr Infect Dis J. 2010. doi: 10.1097/INF.0b013e3181e5292f.
48. BR Kittang N Langeland H Mylvaganam 2008 Distribution of emm types, subtypes among noninvasive group A, C and G streptococcal isolates in western Norway APMIS 116 457 464 1:CAS:528:DC%2BD1cXpslKisLY%3D 10.1111/j.1600-0463. 2008.00976.x 18754319
49. DJ Biedenbach MA Toleman TR Walsh RN Jones 2006 Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004) Diagn Microbiol Infect Dis 55 119 127 1:CAS:528:DC%2BD28XltFOrsrg%3D 10.1016/j.diagmicrobio.2005.12.006 16530373 (Pubitemid 43792405)
50. Pinho MD, Melo-Cristino J, Ramirez M. Fluoroquinolone resistance in Streptococcus dysgalactiae subsp. equisimilis and evidence for a shared global gene pool with Streptoccocus pyogenes. Antimicrob Agents Chemother. doi: 10.1128/AAC.01377-09.
51. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: seventeenth informational supplement. CLSI document M100-S17. Wayne, PA: CLSI; 2007.
52. LC Liu JC Tsai PR Hsueh SP Tseng WC Hung HJ Chen, et al. 2008 Identification of tet(S) gene area in tetracycline-resistant Streptococcus dysgalactiae subsp. equisimilis clinical isolates J Antimicrob Chemother 61 453 455 1:CAS:528:DC%2BD1cXptlKjsw%3D%3D 10.1093/jac/dkm500 18156606
53. Y Uh GY Hwang IH Jang HM Cho SM Noh HY Kim, et al. 2007 Macrolide resistance trends in beta-hemolytic streptococci in a tertiary Korean hospital Yonsei Med J 48 773 778 1:CAS:528:DC%2BD2sXhsVantr%2FK 10.3349/ymj.2007.48.5.773 17963333 (Pubitemid 350130466)
54. V Savini C Catavitello M Talia A Manna F Pompetti G Di Bonaventura, et al. 2008 β-Lactam failure in treatment of two group G Streptococcus dysgalactiae subsp. equisimilis pharyngitis patients J Clin Microbiol 46 814 816 10.1128/JCM.00985-07 18057124 (Pubitemid 351231346)
55. F Lessa GF Leparc K Benson R Sanderson CA Van Beneden PL Shewmaker, et al. 2008 Fatal group C streptococcal infection due to transfusion of a bacterially contaminated pooled platelet unit despite routine bacterial culture screening Transfusion 48 2177 2183 10.1111/j.1537-2995.2008.01802.x 18564393
56. JO Bay O Tournilhac E Ducher JP Romaszko A Ergani A Bouvet, et al. 2009 A near fatal septic transfusion reaction due to Streptococcus dysgalactiae subspecies equisimilis calls for novel safety measures Vox Sang 96 271 10.1111/j.1423-0410.2008.001150.x 19522886
57. R Courbil JP Romaszko H Odent-Malaure P Fabrigli P Chavarin O Tournilhac, et al. 2010 Analysis of a severe septic transfusion reaction with standard platelet concentrate Transfus Clin Biol 17 9 13 1:STN:280:DC%2BC3c7ptValsA%3D%3D 10.1016/j.tracli.2009.12.002 20106699
58. K Kawata T Minakami Y Mori M Katsumi Y Kataoka A Ezawa, et al. 2003 rDNA sequence analyses of Streptococcus dysgalactiae subsp. equisimilis isolates from pigs Int J Syst Evol Microbiol 53 1941 1946 1:CAS:528:DC%2BD2cXhtF2gsQ%3D%3D 10.1099/ijs.0.02666-0 14657127 (Pubitemid 37483855)
59. F Laus S Preziuso A Spaterna F Beribè B Tesei V Cuteri 2007 Clinical and epidemiological investigation of chronic upper respiratory diseases caused by beta-haemolytic Streptococci in horses Comp Immunol Microbiol Infect Dis 30 247 260 1:STN:280:DC%2BD2szjtVSnsw%3D%3D 10.1016/j.cimid.2007.02.003 17433441 (Pubitemid 46825178)
60. D Imai S Jang M Miller PA Conrad 2009 Characterization of beta-hemolytic streptococci isolated from southern sea otters (Enhydra lutris nereis) stranded along the California coast Vet Microbiol 136 378 381 1:CAS:528: DC%2BD1MXltFeltL0%3D 10.1016/j.vetmic.2008.11.009 19117701
61. M Zoric E Nilsson N Lundeheim P Wallgren 2009 Incidence of lameness and abrasions in piglets in identical farrowing pens with four different types of floor Acta Vet Scand 51 23 10.1186/1751-0147-51-23 19463187
62. T Zaoutis M Attia R Gross J Klein 2004 The role of group C and group G streptococci in acute pharyngitis in children Clin Microbiol Infect 10 37 40 1:STN:280:DC%2BD2c%2FlvFKmtA%3D%3D 10.1111/j.1469-0691.2004.00732.x 14706084 (Pubitemid 38128590)
63. PR Smeesters P Mardulyn A Vergison R Leplae L Van Melderen 2008 Genetic diversity of Group A Streptococcus M protein: implications for typing and vaccine development Vaccine 26 5835 5842 1:CAS:528:DC%2BD1cXht1KnsLjF 10.1016/j.vaccine.2008.08.037 18789365
64. JB Dale T Penfound EY Chiang V Long ST Shulman B Beall 2005 Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes Clin Diagn Lab Immunol 12 833 836 1:CAS:528:DC%2BD2MXmslGjt7o%3D 16002631 (Pubitemid 40993282)
65. MC Hu MA Walls SD Stroop MA Reddish B Beall JB Dale 2002 Immunogenicity of a 26-valent group A streptococcal vaccine Infect Immun 70 2171 2177 1:CAS:528:DC%2BD38Xitl2lsLo%3D 10.1128/IAI.70.4.2171-2177.2002 11895984 (Pubitemid 34242220)
66. SA McNeil SA Halperin JM Langley B Smith A Warren GP Sharratt, et al. 2005 Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers Clin Infect Dis 41 1114 1122 1:CAS:528: DC%2BD2MXhtFKgsr7O 10.1086/444458 16163629 (Pubitemid 41429473)
67. R Nir-Paz Z Korenman M Ron A Michael-Gayego R Cohen-Poradosu L Valinsky, et al. 2010 Streptococcus pyogenes emm and T types within a decade, 1996-2005: implications for epidemiology and future vaccines Epidemiol Infect 138 53 60 1:CAS:528:DC%2BD1MXhsV2is7nJ 10.1017/S0950268809002805 19480723
68. L Guilherme KC Faé F Higa L Chaves SE Oshiro S Freschi de Barros, et al. 2006 Towards a vaccine against rheumatic fever Clin Dev Immunol 13 125 132 1:CAS:528:DC%2BD2sXps1SjtA%3D%3D 10.1080/17402520600877026 17162355 (Pubitemid 44950031)
69. H Vohra N Dey S Gupta AK Sharma R Kumar D McMillan, et al. 2005 M protein conserved region antibodies opsonise multiple strains of Streptococcus pyogenes with sequence variations in C-repeats Res Microbiol 156 575 582 1:CAS:528:DC%2BD2MXjvVOju74%3D 10.1016/j.resmic.2004.12.009 15862457 (Pubitemid 40615426)
70. N Yoonim C Olive C Pruksachatkunakorn S Pruksakorn 2006 Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population BMC Microbiol 6 71 10.1186/1471-2180-6-71 16895610 (Pubitemid 44319297)